Back to Search
Start Over
Targeted disruption of pi-pi stacking in Malaysian banana lectin reduces mitogenicity while preserving antiviral activity
- Source :
- Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021), Scientific Reports
- Publication Year :
- 2021
- Publisher :
- NATURE RESEARCH, 2021.
-
Abstract
- Lectins, carbohydrate-binding proteins, have been regarded as potential antiviral agents, as some can bind glycans on viral surface glycoproteins and inactivate their functions. However, clinical development of lectins has been stalled by the mitogenicity of many of these proteins, which is the ability to stimulate deleterious proliferation, especially of immune cells. We previously demonstrated that the mitogenic and antiviral activities of a lectin (banana lectin, BanLec) can be separated via a single amino acid mutation, histidine to threonine at position 84 (H84T), within the third Greek key. The resulting lectin, H84T BanLec, is virtually non-mitogenic but retains antiviral activity. Decreased mitogenicity was associated with disruption of pi-pi stacking between two aromatic amino acids. To examine whether we could provide further proof-of-principle of the ability to separate these two distinct lectin functions, we identified another lectin, Malaysian banana lectin (Malay BanLec), with similar structural features as BanLec, including pi-pi stacking, but with only 63% amino acid identity, and showed that it is both mitogenic and potently antiviral. We then engineered an F84T mutation expected to disrupt pi-pi stacking, analogous to H84T. As predicted, F84T Malay BanLec (F84T) was less mitogenic than wild type. However, F84T maintained strong antiviral activity and inhibited replication of HIV, Ebola, and other viruses. The F84T mutation disrupted pi-pi stacking without disrupting the overall lectin structure. These findings show that pi-pi stacking in the third Greek key is a conserved mitogenic motif in these two jacalin-related lectins BanLec and Malay BanLec, and further highlight the potential to rationally engineer antiviral lectins for therapeutic purposes. ispartof: SCIENTIFIC REPORTS vol:11 issue:1 ispartof: location:England status: published
- Subjects :
- 0301 basic medicine
Glycan
Science
Glycobiology
BanLec
HIV Infections
Virus Replication
Antiviral Agents
Article
03 medical and health sciences
Lectins
Virology
Humans
Threonine
Histidine
Cells, Cultured
Cell Proliferation
chemistry.chemical_classification
Multidisciplinary
030102 biochemistry & molecular biology
biology
Chemistry
Antimicrobials
Wild type
Lectin
Musa
Hemorrhagic Fever, Ebola
Ebolavirus
Amino acid
030104 developmental biology
Biochemistry
Viral replication
biology.protein
HIV-1
Leukocytes, Mononuclear
Medicine
Mitogens
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021), Scientific Reports
- Accession number :
- edsair.doi.dedup.....384a96afd44721ec1a9cfcd80d190ab4